VEONA SINANON: Open Payments
NPI 1508569807 · GROVELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 15 payments from 10 companies in 2025. Trend: 2023 $1,491 · 2024 $2,258 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $67 |
| Tris Pharma Inc | 2 | $48 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Lundbeck LLC | 1 | $28 |
| Almatica Pharma LLC | 1 | $28 |
| Alkermes, Inc. | 1 | $25 |
| Validus Pharmaceuticals LLC | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: VRAYLAR, Dyanavel XR, Qelbree, COBENFY, REXULTI, LOREEV XR, LYBALVI, EQUETRO.
Industry payments across FL — which companies pay providers there.
